Abstract Mycoplasma contamination is a deleterious event for cell culture laboratories. Plasmocin TM is used to prevent and eradicate mycoplasma infections from cell. In this study, 80 different mammalian cell lines from various sources; human, monkey, mice, hamster and rat were used to study and evaluate plasmocin TM efficiency and compare it to commonly used antibiotics such as BM-cyclin, ciprofloxacin and mycoplasma removal agent (MRA). It was shown that mycoplasma infections were eradicated by plasmocin TM , BM-cyclin, ciprofloxacin and MRA in 65%, 66.25%, 20%, and 31.25%, respectively, of infected cell cultures. However, re-infection with mycoplasmas after the period of 4 months occurred in 10-80% of the studied cell lines. Cell cytotoxicity and culture death was observed in 25, 17.5 and 10% of the treated cells, for plasmocin TM , BM-cyclin and MRA, respectively. In this study, Plasmocin TM showed strong ability to eradicate mollicutes from our cell lines with minimal percentage of regrowth. However, due to its high cell cytotoxicity it should be used with caution especially when dealing with expensive or hard-to-obtain cell lines. Amongst the antibiotics tested, BM-cyclin was shown to remove mycoplasma with the highest efficiency.
Introduction
Human and animal continuous cell lines are precious and indispensable tools for both biotechnological and biomedical research. In this respect, mycoplasma contamination is a deleterious event for a cell culture laboratory resulting in the production of false data or, in the worst cases, in the loss of cell culture itself (Mariotti et al. 2008) . It is well-known that mycoplasma can have adverse effects on cell cultures such as altered levels of protein and of RNA/DNA synthesis, induction of chromosomal aberrations, changes in cell membrane composition and modification of cellular morphology . It has been highly advised to autoclave and discard infected cultures to minimize the risk of infection transmission to other clean cultures and eradication strategies in a separate quarantine laboratory should be considered as a last resort, if a valuable cell line or primary cell culture is not replaceable (Molla Kazemiha et al. 2009 ). For eradication purposes, three classes of antibiotics, i.e., tetracyclines, macrolides and quinolones, have been shown to be highly effective against mycoplasmas, both in human/veterinary medicine and in cell culture (Singh et al. 2008; Uphoff and Drexler 2005) . Since each antibiotic has its own activity and might not completely treat all the mycoplasma contaminants present in a culture, using a combination of antibiotics have attracted a lot of attentions. To this end, Plasmocin (Macrolid), have been used to prevent and eradicate mycoplasma infections from cell lines. The use of Plasmocin for eliminating mycoplasma from particular cell lines has been studied previously (Bronckaers et al. 2008; Singh et al. 2008; Mnif et al. 2007 ). There are also some studies on the efficacy of commonly used antibiotics such as Ciprofloxacine (Ridgway et al. 1984; Mowles 1988) , BM-Cycline (Shin et al. 2003) , and Mycoplasma removal agent (Drexler 1994; Nakai et al. 2000; Souza et al. 2007) . However, few studies have reported on the comparison of these four antibiotics (Plasmocin, Ciprofloxacine, BM-Cycline and Mycoplasma removal agent) on the mycoplasma eradication from different cell lines. Previously, we reported the types of contaminants of our cell cultures and eradication strategies using three commonly used antibiotics (Molla Kazemiha et al. 2009) . In this study, we aimed to compare the efficacy of Plasmocin TM against three previously studied antibiotics; BM-Cycline, Ciprofloxacine and MRA for decontamination of various mammalian cell lines.
Materials and methods

Cell cultures
A total of 80 different cell types (Table 1) from the National Cell Bank of Iran (Pasteur Institute of Iran, Tehran, Iran) were analyzed in this study. Cell lines were grown at 37°C in a humidified atmosphere of air containing 5% CO 2 . The basic growth media were supplemented with 10-20% fetal bovine serum (Sigma, Deisenhofen, Germany). For growth factordependent cell lines, specific growth factors or conditioned media containing growth factors were added (Drexler et al. 2001 (bFGF, Cat No: F 5392) , and Human Endothelial Cell Growth Factor (Cat No: E 9640) were purchased from Sigma. All supplements, such as serum, conditioned media and trypsin were mycoplasma negative as indicated by the suppliers. For detection of mycoplasma, the cell lines were cultured initially for at least 1 week after thawing, and samples were taken after a culture period of at least 2 days without medium exchange. No antibiotics were added to the cultures.
Detection of mollicutes
The mycoplasma contamination status in 80 cell lines was determined using PCR-based method as described by Molla kazemiha et al. (2009) . Table 2 shows the primer sequences with melting temperature (Tm) and guanine-cytosine content (GC %). All primers were obtained from CinnaGene (Iran) company.
Previous studied cell lines (Molla kazemiha et al. 2009) were treated with Plasmocin TM (Invivogen, USA, cat. No 04J05-SV) and the Plasmocin TM efficacy compared with previously used antibiotics, Mannheim, Germany, cat. No.799050) , Ciprofloxacin (ICN, USA, cat. No. 199020) and MRA (Serotec, UK, cat. No, Buf035) . Moreover, another 40 new cell lines were screened for their mycoplasma contamination status and treated with above mentioned four antibiotics. The effects of each antibiotic on culture death as well as eradication and regrowth of mycoplasma were evaluated. Samples were treated with the antibiotics with doses and duration as stated below:
1. Plasmocin TM was added for 14 days at a final concentration of 25 lg/mL. 2. BM-Cyclin I (10 lg/mL) and BM-Cyclin II (5 lg/mL) were used in three alternating cycle of 3 and 4 days, respectively. 
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Ciprofloxacin was used for 14 days at10 lg/mL. 4. MRA was added to the culture medium for 10 days at a final concentration of 0.5 lg/mL.
The concentration of Plasmocin, BM cyclin and MRA were chosen according to the manufacturer's instructions. Ciprofloxacin concentration was specified according to the published report (Fleckenstein and Drexler 1996) . Following the treatment with these reagents, cells were cultured in antibiotic-free medium (also without penicillin, streptomycin or other commonly used antibiotics) for at least another 2 weeks prior to testing for residual mycoplasmal contamination. All cured cultures were retested for regrowth of mycoplasmas for up to 4 months following the treatment.
Statistical analysis
All statistical analyses were performed with SPSS 16.0 (IBM Ò SPSS Ò Statistics, USA). Since the data were ordinal and non-normally distributed, non-parametric Kruskal-Wallis analysis was used for comparison of the 4 groups, and two-by-two comparisons were made using the Mann-Whitney U test. Differences at P \ 0.05 were considered to be statistically significant. 
Results
Determination of mycoplasma contamination status
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Eradication of mycoplasmal contamination
The results obtained from eradication experiments (mycoplasma removal) are summarized in Fig. 1 and Table 3 . Mycoplasma infections were eliminated by BM-Cyclin, Plasmocin TM , MRA and Ciprofloxacin and in 66.25, 65, 31.25 and 20% of the infected cell cultures, respectively. Furthermore, the decontamination was confirmed by PCR, as no mycoplasma was detected in treated cultures 14 days after completion of antibiotic treatment (Fleckenstein and Drexler 1996) . Mycoplasma regrowth was observed in 10, 16.25, 80 and 58.75% of the cured cell lines 4 months after treatment with Plasmocin TM , BM-cyclin, ciprofloxacin and MRA, respectively. In spite of the absence of Plasmocin TM -targets in eukaryotic cells, the highest level (25%) of cell cytotoxicity was observed among Plasmocin TM treated cell lines. While BM-cyclin, ciprofloxacin and MRA were Mhy cytotoxic up to 17.5, 0, and 10% of the studied cell lines (Fig. 1) . Notably, except in one case, regrowth problem for BM-cyclin treated cell lines could be solved by its replacement with Plasmocin TM and vice versa. The statistical results of two-by-two comparisons are indicated in Table 4 with significant differences between four groups but not between the Plasmocin TM /BM-cyclin and MRA/Ciprofloxacin.
Discussion
Methods of elimination should ideally be simple, easy, rapid, efficient, reliable and inexpensive and have minimal effect on the eukaryotic cells. However, there is clearly not a single method available that is both 100% effective and fulfills all the ideal requirements. To this end, administration of antibiotics is the most common and efficient approach . Obviously it is important to know the efficacy of the antibiotics for the Mho, M. hominis; Mge, M. genitalium; Uur, U. urealyticum; (-), non-detected mycoplasma species; (?), detected species-specific mycoplasma eradication of mycoplasma in cultures, as well as the practicality of the approach, and the potential sideeffects on the eukaryotic cells . The antibiotic effectiveness for eradication of each strain of mycoplasma is related to several parameters including cell types, cell species (human or animal) and severity of infection. In addition, some cell types may be infected with several species making it difficult to draw an accurate conclusion.
The mechanism of action of each antibiotic is different. Plasmocin (Macrolid and quinolone) acts on the protein machinery and also on DNA replication by interfering with ribosomal translation and replication fork, respectively. BM-Cyclin binds to the 30S and 50S ribosomal subunits and inhibits protein synthesis. According to the manufacturer's information, the bactericidal components of BM cyclin (Roche) are composed of pleuromutilin and tetracycline while Plasmocin TM (InvivoGen) is composed of a macrolide and a quinolone. On the other hand, MRA and Ciprofloxacin are members of the quinolones family inhibiting bacterial DNA gyrase and replication of DNA (Helgason and Miller 2005; Drexler 2004, 2011) .
Plasmocin TM and BM-Cyclin were efficient in removing mollicutes and curing 65 and 66.25% of our cell lines, respectively. While, Ciprofloxacin and MRA were considerably less efficient as they cured only 20 and 31.25% of our cell lines, respectively. The high efficiency of Plasmocin and BM-Cyclin were not surprising as they are composed of two types of bactericidal agents (www. plasmocin.com, Uphoff et al. 2002) . Zakharova et al. (2010) showed that Plasmocin can effectively remove mycoplasma contamination in treatment of chronic mycoplasma infections.
Notably, Plasmocin TM and BM-Cyclin were highly efficient especially in curing of M. orale, M. hyorhinis and M. arginini infected cell lines which were resistant to other antibiotics used in this study. Fleckenstein and Drexler (1996) also reported these strains as resistant strains. For instance, we observed high level of ciprofloxacin as well as MRA resistance/regrowth after treating cell lines infected with above mentioned mollicutes.
As for regrowth, Plasmocin TM showed the lowest level (10%) in our experiment, while regrowth was observed in 16.25% of cell lines after treating with BM-Cyclin. On the other hand, ciprofloxacin and MRA showed striking levels of regrowth (80 and 58.75% respectively) in treated cells. It has been shown by other researchers that ciprofloxacin may increase the mycoplasma resistance to antibiotic treatment (Momynaliev et al. 2002) . Interestingly, for each cell lines (except for J774 in which regrowth was observed after treating with all the studied antibiotics) for which regrowth was observed after BM-Cyclin treatment, Plasmocin TM may solve the problem and vice versa. Surprisingly, Plasmocin TM showed the highest percentage (25%) of culture death, although plasmocin TM targets, the prokaryotic DNA replication and protein synthesis machineries, which are totally different from those of eukaryotic cells (www.plasmocin. com). However, Because of these two combined mechanisms, the cells are more affected by the antibiotic activity and the environment is more toxic for cells. Similarly, Singh et al. (2008) lost their culture during plasmocin TM treatment. BM-Cyclin showed slightly lower cytotoxic effects on the studied cell lines. Therefore, it might reduce the risk of culture loss, especially in the case of expensive or hard-to-obtain cell lines to treat with BM-Cyclin first before treating with Plasmocin.
Since the higher amount of culture death was observed during treatment with Plasmocin TM or BMcyclin, treatment with other antibiotics such as MRA or ciprofloxacin must be considered spontaneously in the case of valuable cell lines.
On the other hand, ciprofloxacin showed no cell cytotoxicity at all, while MRA caused 10% cell death during or after treatment. Although cytotoxic effect of ciprofloxacin was not detected in this study, such observation has been reported before (Fleckenstein and Drexler 1996; Kloskowski et al. 2010; Sousa and Poiares-da-Silva 2001) . Although the latter two antibiotics, showed lower percentage of cell cytotoxicity, they are not recommendable as they exhibited poor results in curing and regrowth experiments.
It is well known that several parameters are changed during infection of cultured cells by mycoplasma including reduction in the number of chromosomes in the cells or difficulty in the interpretation of the results of enzymatic activity (Souza et al. 2007 ). On the other hand different antibiotic doses administered during antibiotic treatment may cause different effects on cultured cells. Therefore it is difficult to detect and assess the effect of antibiotic treatment on the cell cycle stages during treatment of mycoplasmal infected cells. There are few studies on the antibiotic administration and its effect on different stages of the cell cycle. It has been reported that antibiotics may inhibit the cell proliferation and cause cell cycle arrest at the G2/M phase (Tsai et al. 2008; Koziel et al. 2010) . For this reason the antibiotic concentration should be determined precisely while apoptosis induction or mitosis inhibition should be considered.
The combination of two or more antibiotics with different action mechanisms for treatment of a single cell culture makes the interpretation of the results more complicated. Based on our experiment this might increase the risk of culture death or antibiotic resistance of bacteria. For this reason we suggest that using two or more antibiotics in an alternating procedure may be suitable for a successful eradication. For example BM cyclin (inhibits the protein synthesis) and Ciprofoxacin (inhibits the DNA gyrase activity) with different action mechanisms can be used alternately during treatment period with specified intervals. It should be noted that the outcomes of cocktail effects are under investigation and will be discussed in more detail in the future publications.
In conclusion, results obtained from Plasmocin TM and BM-cyclin in treatment efficacy were almost similar. They exhibited efficient eradication ability with minimum level of regrowth. However, relatively high percentage of cell cytotoxicity for these antibiotics introduces the risk of losing cell lines during the treatment which should be considered especially when dealing with expensive or hard-to-obtain cell lines. Finally it can be concluded that, ciprofloxacin and MRA did not efficiently eradicate mollicutes from the studied cell lines. BM cycline has been chosen as the best antibiotic with the highest amount of cured cells after treatment. Although Plasmocin showed the highest amount of cell death, it can be considered as a selective antibiotic, because of the lowest rate of mycoplasma regrowth compared to the other antibiotics.
